Volunteer Assignments and Opportunities: Difference between revisions
No edit summary |
Snehal.Patel (talk | contribs) No edit summary |
||
| (15 intermediate revisions by 4 users not shown) | |||
| Line 344: | Line 344: | ||
| | | | ||
|Jennelle Hodge (JH)/ Malini Sathanoori (MS) | |Jennelle Hodge (JH)/ Malini Sathanoori (MS) | ||
| | |04/26/2021 -MS (re-review) | ||
| | | | ||
|- | |- | ||
| Line 360: | Line 360: | ||
|PENDING | |PENDING | ||
| ||JH / MS | | ||JH / MS | ||
| | |04/26/2021 -MS (re-review) | ||
| | | | ||
|- | |- | ||
| Line 400: | Line 400: | ||
|Complete | |Complete | ||
| ||JH / MS | | ||JH / MS | ||
| | |04/26/2021 -MS (re-review) | ||
| | | | ||
|- | |- | ||
| Line 417: | Line 417: | ||
|Complete | |Complete | ||
| ||JH / MS | | ||JH / MS | ||
|04/26/2021-MS (re-review) | |||
| | | | ||
|- | |- | ||
| Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke | | Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke | ||
| Line 834: | Line 834: | ||
| | | | ||
|- | |- | ||
| B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease|| | | B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease||Holli Drendel | ||
| | | | ||
| | | | ||
|PENDING | |||
| ||YA | | ||YA | ||
| | | | ||
| Line 844: | Line 844: | ||
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4 | |B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4 | ||
|Disease | |Disease | ||
|Diana Rush | |||
| | | | ||
| | | | ||
| | |PENDING | ||
| | | | ||
|YA | |YA | ||
| Line 855: | Line 855: | ||
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6 | |B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6 | ||
|Disease | |Disease | ||
|Celeste Eno | |||
| | | | ||
| | | | ||
| | |PENDING | ||
| | | | ||
|YA | |YA | ||
| Line 864: | Line 864: | ||
|NON-WHO ENTITY | |NON-WHO ENTITY | ||
|- | |- | ||
| | |B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements | ||
|Disease | |||
|Marilena Melas | |||
| | | | ||
| | | | ||
|PENDING | |||
| | | | ||
|YA | |||
| | | | ||
|NON-WHO ENTITY | |||
|- | |- | ||
| | |B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions | ||
|Disease | |||
|Chenkai Ma | |||
| | | | ||
| | | | ||
|PENDING | |||
| | | | ||
|YA | |||
| | | | ||
|NON-WHO ENTITY | |||
|- | |- | ||
| | |B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19) | ||
|Disease | |||
|Celeste Eno | |||
| | | | ||
| | | | ||
|PENDING | |||
| | | | ||
|YA | |||
| | | | ||
|NON-WHO ENTITY | |||
|- | |- | ||
|B-Lymphoblastic Leukemia/Lymphoma with | |B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11) | ||
|Disease | |Disease | ||
| | |Alaa Koleilat | ||
| | | | ||
| | | | ||
| Line 899: | Line 908: | ||
|NON-WHO ENTITY | |NON-WHO ENTITY | ||
|- | |- | ||
| || || | |'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang | ||
| | |||
| | |||
|PENDING | |||
| ||YA | |||
| | |||
| | |||
|- | |||
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang | |||
| | |||
| | |||
|PENDING | |||
| ||YA | |||
| | |||
| | |||
|- | |||
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang | |||
| | |||
| | |||
|PENDING | |||
| ||YA | |||
| | |||
| | |||
|- | |||
| || || | |||
| | | | ||
| | | | ||
| Line 915: | Line 948: | ||
| | | | ||
|- | |- | ||
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease|| | |Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease|| | ||
| | |||
| | | | ||
| | | | ||
| | | | ||
|SP | |SP | ||
| Line 924: | Line 957: | ||
| | | | ||
|- | |- | ||
| Monoclonal B-cell Lymphocytosis||Disease|| | | Monoclonal B-cell Lymphocytosis||Disease|| | ||
| | |||
| | | | ||
| | | | ||
| | | | ||
|SP | |SP | ||
| Line 933: | Line 966: | ||
| | | | ||
|- | |- | ||
|B-cell Prolymphocytic Leukemia||Disease|| | |B-cell Prolymphocytic Leukemia||Disease|| | ||
| | |||
| | | | ||
| | | | ||
| | | | ||
|SP | |SP | ||
| Line 987: | Line 1,020: | ||
| | | | ||
|- | |- | ||
|Lymphoplasmacytic Lymphoma||Disease|| | |Lymphoplasmacytic Lymphoma||Disease|| | ||
| | |||
| | | | ||
| | | | ||
| | | | ||
|SP | |SP | ||
| Line 996: | Line 1,029: | ||
| | | | ||
|- | |- | ||
| Waldenstrom Macroglobulinemia||Disease|| | | Waldenstrom Macroglobulinemia||Disease|| | ||
| | |||
| | | | ||
| | | | ||
| | | | ||
|SP | |SP | ||
| Line 1,032: | Line 1,065: | ||
| | | | ||
| | | | ||
| | |Complete | ||
| ||SP | |5/26/2021||SP | ||
| | | | ||
| | | | ||
| Line 1,045: | Line 1,078: | ||
| | | | ||
|- | |- | ||
|Plasma Cell Neoplasms||'''''Overview'''''|| | |Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang | ||
| | | | ||
| | | | ||
|PENDING | |||
| | | | ||
|SP | |SP | ||
| Line 1,054: | Line 1,087: | ||
| | | | ||
|- | |- | ||
| Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| | | Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Zhenya Tang | ||
| | | | ||
| | | | ||
|PENDING | |||
| | | | ||
|SP | |SP | ||
| Line 1,072: | Line 1,105: | ||
| | | | ||
|- | |- | ||
| Plasma Cell Myeloma | | Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear | ||
| | | | ||
| | | | ||
| Line 1,081: | Line 1,114: | ||
| | | | ||
|- | |- | ||
| Plasmacytoma||Disease|| | | Plasmacytoma||Disease||Zhenya Tang | ||
| | | | ||
| | | | ||
| Line 1,150: | Line 1,183: | ||
| | | | ||
| | | | ||
| | |Complete | ||
| ||SP | |5/28/2021||SP | ||
| | | | ||
| | | | ||
| Line 1,182: | Line 1,215: | ||
| | | | ||
|- | |- | ||
| In Situ Follicular Neoplasia||Disease||Ruthann Pfau | | In Situ Follicular Neoplasia||Disease||Ruthann Pfau | ||
| | | | ||
| | | | ||
|PENDING | |PENDING | ||
| | | | ||
|SP | |SP | ||
| | | | ||
| | | | ||
|- | |- | ||
| Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau | | Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau | ||
| | | | ||
| | | | ||
|PENDING | |PENDING | ||
| | | | ||
|SP | |SP | ||
| | | | ||
| | | | ||
|- | |- | ||
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee) | |Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee) | ||
| | | | ||
| | | | ||
|Complete | |||
|8/16/2020 | |||
|SP | |||
| | |||
| | |||
|- | |||
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid | |||
| | |||
|9/30/20 | |||
|Complete | |Complete | ||
| | |5/26/2021||SP | ||
| | | | ||
| | | | ||
| Line 2,723: | Line 2,756: | ||
| | | | ||
|- | |- | ||
| | |BRCA1 | ||
| | | | ||
| | | | ||
| Line 2,733: | Line 2,766: | ||
| | | | ||
|- | |- | ||
| | |BRCA2 | ||
| | | | ||
| | | | ||